CR

CARE Ratings Ltd

Q2 FY25Capital Markets

CARE Ratings Q2 FY25 earnings call: Revenue & Margins

Q2 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹1,617
Market cap₹5.0K Cr
P/E28.3
Updated25 Sept 2026
Read3 min read

Based on CARE Ratings Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Consolidated Revenue from Operations Q2 FY25: Rs. Standalone Q2 FY25: - Revenue from Operations: Rs.

From CARE Ratings Ltd's Q2 FY25 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Consolidated Revenue from Operations Q2 FY25: Rs. 196.29 Crs, up 21% YoY (Page 13, 2, 12)
  • Standalone Revenue from Operations Q2 FY25: Rs. 166.85 Crs, up 18% YoY (Page 12, 2)
  • Ratings Business Revenue YoY growth: 19%, Rs. 177.63 Crs for H1FY25 (Page 14, 2)
  • Non-Ratings Business Revenue YoY growth: 37%, Rs. 18.66 Crs for H1FY25 (Page 14, 2)

2 more points management made on revenue & sales performance

Profitability & Margins

See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not describe any specific capex, capacity expansion, or new plant/project details, including amounts, status, or timelines. The focus is primarily on financial performance, business segments, market activities, and strategic initiatives such as: - Entry into the Global Scale Ratings space through CareEdge Global IFSC Ltd. - Expansion in subsidiaries including CARE Ratings South Africa and CARE Ratings Nepal.

2 more points management made on capital expenditure plans

Top-ranked in Capital Markets

Ranked on what management guided this quarter

5x potential
1BSE
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation of CARE Ratings Limited does not explicitly report any details on order book, order inflow, or pending orders. The document primarily focuses on: - Financial performance highlights (revenue, EBITDA, PAT) - Segmental revenue contributions (Ratings vs. Non-Ratings) - Business growth in Credit Ratings and advisory services - Key macroeconomic indicators and credit growth trends - Fundraising activities in the economy (corporate bonds and commercial papers)

2 more points management made on order book & pipeline

CARE Ratings Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Capital Markets this season

  • IIFL Capital Services Ltd (Q2 FY25)

    Revenue for Q2 FY25: ₹7,037 million, up 32% YoY from ₹5,337 million in Q2 FY24 (Page 20) . Key concall takeaways from IIFL Capital Services Ltd's Q2 FY25…

  • Geojit Financial Services Ltd (Q2 FY25)

    Market Capitalization as on 30th September 2024: ₹3,690 crore . Key concall takeaways from Geojit Financial Services Ltd's Q2 FY25 earnings call — and how it…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were CARE Ratings Ltd Q2 FY25 results?

Consolidated Revenue from Operations Q2 FY25: Rs. Standalone Q2 FY25: - Revenue from Operations: Rs.

What is CARE Ratings Ltd share price analysis?

CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.

Is CARE Ratings Ltd planning capital expenditure?

The investor presentation does not describe any specific capex, capacity expansion, or new plant/project details, including amounts, status, or timelines.

Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.